Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23973861)

1.

The extent and the nature of the cholinergic contribution to the hepatic encephalopathy-induced cognitive impairment.

Zarros A, Boomkamp SD, Tsakiris S, Baillie GS.

Free Radic Biol Med. 2013 Dec;65:1516-7. doi: 10.1016/j.freeradbiomed.2013.08.165. Epub 2013 Aug 22. No abstract available.

PMID:
23973861
2.

Preventive effect of N-acetyl-L-cysteine on oxidative stress and cognitive impairment in hepatic encephalopathy following bile duct ligation.

Dhanda S, Kaur S, Sandhir R.

Free Radic Biol Med. 2013 Mar;56:204-15. doi: 10.1016/j.freeradbiomed.2012.09.017. Epub 2012 Oct 5.

PMID:
23044263
3.

Cognitive deficits associated with chronic hepatic encephalopathy and their response to levodopa.

Elithorn A, Lunzer M, Weinman J.

J Neurol Neurosurg Psychiatry. 1975 Aug;38(8):794-8.

4.

Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.

Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V.

Gastroenterology. 2010 Aug;139(2):675-84. doi: 10.1053/j.gastro.2010.03.040. Epub 2010 Mar 18.

PMID:
20303348
5.

Does overt hepatic encephalopathy cause persistent cognitive defects even after successful liver transplantation?

Allampati S, Mullen KD.

Liver Transpl. 2014 Aug;20(8):874-5. doi: 10.1002/lt.23938. No abstract available.

6.

Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation.

Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM.

J Hepatol. 2009 Sep;51(3):528-34. doi: 10.1016/j.jhep.2009.04.021. Epub 2009 May 27.

PMID:
19596476
7.

Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

Riggio O, Ridola L, Pasquale C, Nardelli S, Pentassuglio I, Moscucci F, Merli M.

Clin Gastroenterol Hepatol. 2011 Feb;9(2):181-3. doi: 10.1016/j.cgh.2010.10.002. Epub 2010 Oct 15.

PMID:
20951832
8.

Helicobacter pylori might contribute to persistent cognitive impairment after resolution of overt hepatic encephalopathy.

Kountouras J, Zavos C, Deretzi G.

Clin Gastroenterol Hepatol. 2011 Jul;9(7):624; author reply 624-5. doi: 10.1016/j.cgh.2011.02.011. Epub 2011 Feb 17. No abstract available.

PMID:
21334456
9.

N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms.

Bémeur C, Vaquero J, Desjardins P, Butterworth RF.

Metab Brain Dis. 2010 Jun;25(2):241-9. doi: 10.1007/s11011-010-9201-2. Epub 2010 Apr 30.

PMID:
20431929
10.

Acarbose treatment in liver disease: cognitive or glycemic control?

Stewart CA, Vella A.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):108-9. No abstract available.

PMID:
15704043
11.

Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Seyan AS, Hughes RD, Shawcross DL.

World J Gastroenterol. 2010 Jul 21;16(27):3347-57. Review.

12.

Brain cholinergic impairment in liver failure.

García-Ayllón MS, Cauli O, Silveyra MX, Rodrigo R, Candela A, Compañ A, Jover R, Pérez-Mateo M, Martínez S, Felipo V, Sáez-Valero J.

Brain. 2008 Nov;131(Pt 11):2946-56. doi: 10.1093/brain/awn209. Epub 2008 Sep 4.

13.

N-acetylcysteine reverses existing cognitive impairment and increased oxidative stress in glutamate transporter type 3 deficient mice.

Cao L, Li L, Zuo Z.

Neuroscience. 2012 Sep 18;220:85-9. doi: 10.1016/j.neuroscience.2012.06.044. Epub 2012 Jun 23.

14.

Hepatic encephalopathy evaluated by automatic period analysis of the electroencephalogram during lactulose treatment.

Kardel T, Olsen PZ, Stigsby B, Tonnesen K.

Acta Med Scand. 1972 Dec;192(6):493-8. No abstract available.

PMID:
4640695
15.

Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.

Huang Q, Aluise CD, Joshi G, Sultana R, St Clair DK, Markesbery WR, Butterfield DA.

J Neurosci Res. 2010 Sep;88(12):2618-29. doi: 10.1002/jnr.22422.

PMID:
20648652
16.

Fish oil has beneficial effects on behavior impairment and oxidative stress in rats subjected to a hepatic encephalopathy model.

Staziaki PV, Marques CM, Delattre AM, de Paula Cioni B, Rufino M, Dos Santos FV, Licks F, Marroni NP, Ferraz AC.

CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):84-93.

PMID:
23244424
17.

Protective effect of N-acetylcysteine on bisphenol A-induced cognitive dysfunction and oxidative stress in rats.

Jain S, Kumar CH, Suranagi UD, Mediratta PK.

Food Chem Toxicol. 2011 Jun;49(6):1404-9. doi: 10.1016/j.fct.2011.03.032. Epub 2011 Mar 31.

PMID:
21440025
18.

Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes.

Kamboj SS, Chopra K, Sandhir R.

Metab Brain Dis. 2008 Dec;23(4):427-43. doi: 10.1007/s11011-008-9104-7. Epub 2008 Sep 19.

PMID:
18802743
19.

Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival.

Stravitz RT, Sanyal AJ, Reisch J, Bajaj JS, Mirshahi F, Cheng J, Lee WM; Acute Liver Failure Study Group.

Liver Int. 2013 Oct;33(9):1324-31. doi: 10.1111/liv.12214. Epub 2013 Jun 19.

PMID:
23782487
20.

Effect of N-acetyl cysteine against aluminium-induced cognitive dysfunction and oxidative damage in rats.

Prakash A, Kumar A.

Basic Clin Pharmacol Toxicol. 2009 Aug;105(2):98-104. doi: 10.1111/j.1742-7843.2009.00404.x. Epub 2009 Mar 27.

PMID:
19389043
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk